These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1695)

  • 21. Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
    Davidson C; Thadani U; Singleton W; Taylor SH
    Br Med J; 1976 Jul; 2(6026):7-9. PubMed ID: 7342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
    Rosendorff C; Goodman C; Coull A
    J Clin Pharmacol; 1985 Apr; 25(3):233-6. PubMed ID: 2860134
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative trial of timolol and flutonidin as antihypertensive agents.
    Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of timolol maleate, hydrochlorothiazide and amiloride hydrochloride in the treatment of hypertension: A multicentre trial.
    Burns DG; Pittaway D
    S Afr Med J; 1980 May; 57(20):815-8. PubMed ID: 6996128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker.
    Dahlöf B; Sjöberg KH; Flygt C; Jern S; Hansen S; Hansson L
    J Cardiovasc Pharmacol; 1986; 8(1):55-9. PubMed ID: 2419693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with Timolol maleate (Blocadren, MSD) in Nigerian hypertensives.
    Falase AO; Salako LA
    Niger Med J; 1979 Apr; 9(4):453-9. PubMed ID: 539114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

  • 31. Timolol maleate (blocadren) in the treatment of hypertension.
    Levitt D
    East Afr Med J; 1977 Oct; 54(10):582-5. PubMed ID: 608431
    [No Abstract]   [Full Text] [Related]  

  • 32. Short- and long-term therapy of mild essential hypertension with timolol.
    Harris FJ; Tonkin M; Pratt C; DeMaria AN; Amsterdam EA; Mason DT
    Clin Pharmacol Ther; 1981 Dec; 30(6):765-72. PubMed ID: 7030579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of carvedilol in the treatment of hypertension.
    Schnurr E; Widmann L; Glocke M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S101-7. PubMed ID: 2454354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
    Maclean D
    Angiology; 1988 Jun; 39(6):487-96. PubMed ID: 2897812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.
    Dahlöf B; Danielson M; Andersson O; Thulin T; Ohman P; Mörlin C; Boberg J; Karlberg BE; Jern S; Hansson L
    Br J Clin Pharmacol; 1984 Dec; 18(6):831-6. PubMed ID: 6152175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.